Plasma cysteine and glutathione are independent markers of postmethionine load endothelial dysfunction

Clinical Biochemistry

Volumn 40, Issue 3-4, 2007, Pages 188-193

  Parodi, Oberdan ^a   De Chiara, Benedetta ^a   Baldassarre, Damiano ^b   Parolini, Marina ^a   Caruso, Raffaele ^a   Pustina, Linda ^b   Parodi, Guido ^c   Campolo, Jonica ^a   Sedda, Valentina ^a   Baudo, Francesco ^a   Sirtori, Cesare ^b  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Antioxidants; Endothelial function; Flow mediated vasodilation; Homocysteine

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BIOCHEMICAL MARKER; CYSTEINE; CYSTEINYLGLYCINE; GLUTATHIONE; HOMOCYSTEINE; MALONALDEHYDE; METHIONINE;

ADULT; ARTERY DILATATION; ARTICLE; BLOOD SAMPLING; BRACHIAL ARTERY; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; EVALUATION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; INDEPENDENT VARIABLE; LINEAR REGRESSION ANALYSIS; MALE; MULTIVARIATE ANALYSIS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

ADULT; BIOLOGICAL MARKERS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CYSTEINE; ENDOTHELIUM, VASCULAR; GLUTATHIONE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHIONINE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROGNOSIS; REGIONAL BLOOD FLOW; VASODILATION;

EID: 33846258176     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.08.017     Document Type: Article

References (34)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 362 (1993) 801-809
2. Tawakol A., Omland T., Gerhard M., Wu J.T., and Creager M.A. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 95 (1997) 1119-1121
3. Woo K.S., Chook P., Lolin Y.I., et al. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 96 (1997) 2542-2544
4. Chambers J.C., McGregor A., Jean-Marie J., Obeid O.A., and Kooner J.S. Acute hyperhomocysteinemia and endothelial dysfunction. Lancet 351 (1998) 36-37
5. Bellamy M.F., McDowell I.F., Ramsey M.W., et al. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation 98 (1998) 1848-1852
6. Bis Al-Shaer M.H., Raghuveer G., Browning R., et al. Effect of hyperhomocysteinemia induced by methionine administration on flow-mediated dilatation of the brachial artery in healthy subjects. Am. J. Cardiol. 95 (2005) 428-430
7. Upchurch G.R., Welch G.N., Fabian A.J., et al. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J. Biol. Chem. 272 (1997) 17012-17017
8. Starkebaum G., and Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77 (1986) 1370-1376
9. Mansoor M.A., Seljeflot I., Arnesen H., et al. Endothelial cell adhesion molecules in healthy adults during acute hyperhomocysteinemia and mild hypertriglyceridemia. Clin. Biochem. 37 (2004) 408-414
10. Chao C.L., Kuo T.L., and Lee Y.T. Effects of methionine-induced hyperhomocysteinemia on endothelium-dependent vasodilation and oxidative status in healthy adults. Circulation 101 (2000) 485-490
11. Nightingale A.K., James P.P., Morris-Thurgood J., et al. Evidence against oxidative stress as mechanism of endothelial dysfunction in methionine loading model. Am. J. Physiol.: Heart Circ. Physiol. 280 (2001) H1334-H1339
12. Hanratty C.G., McAuley D.F., McGurk C., Young I.S., and Johnston G.D. Homocysteine and endothelial vascular function. Lancet 351 (1998) 1288-1289
13. Mansoor M.A., Guttormsen A.B., Fiskerstrand T., Refsum H., Ueland P.M., and Svardal A.M. Redox status and protein-binding of plasma aminothiols during the transient hyperhomocysteinemia that follows homocysteine administration. Clin. Chem. 39 (1993) 980-985
14. Stamler J.S., and Slivka A. Biological chemistry of thiols in the vasculature and in vascular-related disease. Nutr. Rev. 54 (1996) 1-30
15. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
16. National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143--421.
17. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 (1997) 1183-1197
18. Celermajer D.S., Soresen K.E., Gooch V.M., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340 (1992) 1111-1115
19. Soresen K.E., Celermajer D.S., Spiegelhalter D.J., et al. Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br. Heart J. 74 (1995) 247-253
20. Stadler R.W., Ibrahim S.F., and Lees R.S. Measurement of the time course of peripheral vasoactivity: results in cigarette smokers. Atherosclerosis 138 (1998) 197-205
21. Corretti M.C., Anderson T.J., Benjamin E.J., et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J. Am. Coll. Cardiol. 39 (2002) 257-265
22. Accinni R., Campolo J., Bartesaghi S., et al. High-performance liquid chromatographic determination of total plasma homocysteine with or without internal standards. J. Chromatagr. A 828 (1998) 397-400
23. De Chiara B., Bigi R., Campolo J., et al. Blood glutathione as a marker of cardiac allograft vasculopathy in heart transplant recipients. Clin. Transplant 19 (2005) 367-371
24. Friedman A.N., Bostom A.G., Selhub J., Levey A.S., and Rosenberg I.H. The kidney and homocysteine metabolism. J. Am. Soc. Nephrol. 12 (2001) 2181-2189
25. Cighetti G., Debiasi S., Paroni R., and Allesi P. Free and total malondialdehyde assessment in biological matrices by gas chromatography-mass spectrometry: what is needed for an accurate detection. Anal. Biochem. 266 (1999) 222-229
26. Hultqvist M., Hegbrant J., Nilsson-Thorell C., et al. Plasma concentration of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis. Clin. Nephrol. 47 (1997) 37-46
27. Penco S., Grossi E., Cheng S., et al. Assessment of the role of genetic polymorphism in venous thrombosis through artificial neural networks. Ann. Hum. Genet. 69 (2005) 693-706
28. Bilsborough W., Green Daniel J., Mamotte Cyril D.S., van Bockxmeer Frank M., O'Driscoll Gerard J., and Taylor Roger R. Endothelial nitric oxide synthase gene polymorphism, homocysteine, cholesterol and vascular endothelial function. Atherosclerosis 169 (2003) 131-138
29. Araki A., Sako Y., Fukushima Y., Matsumoto M., Asada T., and Kita T. Plasma sulphydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis 79 (1989) 139-146
30. Mansoor M.A., Bergmark C., Svardal A.M., Lonning P.E., and Ueland P.M. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 232-240
31. El-Khairy L., Ueland P.M., Refsum H., Graham I.M., and Vollset S.E. Plasma total cysteine as a risk factor for vascular disease. The European concerted action project. Circulation 103 (2001) 2544-2549
32. Sheu F.S., Zhu W., and Fung P.C. Direct observation of trapping and release of nitric oxide by glutathione and cysteine with electron paramagnetic resonance spectroscopy. Biophys. J. 78 (2000) 1216-1226
33. Ignarro L.J., Lippton H., Edwards J.C., et al. Mechanisms of vascular smooth muscle relaxation by organic nitrates, nitroprusside and nitric oxide: evidence of the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther. 218 (1981) 739-749
34. Boesgaard S., Poulsen H.E., Aldershvile J., Loft S., Anderson M.E., and Meister A. Acute effects of nitroglycerin depend on both plasma and intracellular sulphydryl compound levels in vivo: effect of agents with different sulphydryl-modulating properties. Circulation 87 (1993) 547-553